Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Director Resignations; Director Appointments On January 5, 2024, in connection with the consummation of the Merger and pursuant to the Merger Agreement, Carlos Paya, M.D., Ph.D., Laura Clague and Martin Madaus, Ph.D. resigned from Standard BioTools’ board of directors (the “Standard BioTools Board”) and ceased serving on the Standard BioTools Board and any and all committees thereof. No director resigned as a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Additionally, the Standard BioTools Board elected and designated Kathy Hibbs, Tom Carey and Troy Cox (each, a “New Director” and collectively, the “New Directors”), who were previously members of SomaLogic’s board of directors, to serve on the Standard BioTools Board and Tom Carey to serve as Chairperson of the Standard BioTools Board, each effective at the consummation of the Merger. Other than as set forth herein, there are no arrangements or understandings with any of the New Directors or any other person pursuant to which such New Director was selected and none of the New Directors has a direct or indirect material interest in any related party transaction required to be disclosed under Item 404(a) of Regulation S-K. In connection with the New Directors’ service on the Standard BioTools Board, each New Director will be eligible to be compensated as directors of Standard BioTools pursuant to Standard BioTools’ outside director compensation policy. The New Directors will also have the same right to indemnification by the Company as granted to the Company’s other non-employee directors. Following the Merger, the composition of the Standard BioTools Board and their respective classes and their respective committees on which the directors will serve are as follows: Class I – Term Expiring in 2026 Class II – Term Expiring in 2024 Class III – Term Expiring in 2025 Class N/A Michael Egholm, Ph.D. Tom Carey Troy Cox Kathy Hibbs Frank Witney, Ph.D. Eli Casdin Fenel Eloi Audit Committee Compensation Committee Nominating and Corporate Governance Committee Fenel Eloi (Chairperson) Troy Cox Kathy Hibbs Frank Witney, Ph.D. Frank Witney, Ph.D. (Chairperson) Eli Casdin Troy Cox Tom Carey (Chairperson) Eli Casdin Kathy Hibbs Amendment to 2011 Equity Incentive Plan As disclosed in